Stock report · Delisted · Nasdaq
NeuroMetrix Inc (NURO)
4.58USD Delisted Final close · May 1, 2025
NURO no longer trades. NeuroMetrix was delisted from the Nasdaq in May 2025.
All prices on this page are historical. The last trade was on May 1, 2025, at $4.58.
NURO stock price history
Final trading statistics
- Final close
- $4.58
- Final trading day
- May 1, 2025
- Market cap at delisting
- $9.43M
- Shares outstanding
- 2.06M
- Final 52-week range
- $2.66 – $4.73
- Avg. volume (final 3 mo.)
- 7,379
- All-time high
- $1000000.00 · Sep 2004
- All-time low
- $2.79 · Aug 2024
- Return since IPO
- -100.0%
- Beta
- 1.83
- Book value / share
- $6.98
- Price / book
- 0.66
About NeuroMetrix Inc
NeuroMetrix was a commercial-stage neurotechnology company that designed and sold medical devices. Its DPNCheck product was a nerve conduction test for evaluating peripheral neuropathies such as diabetic peripheral neuropathy. Quell was a wearable device for relieving and managing chronic pain.
Endocrinologists, podiatrists, primary care doctors and other clinicians used its products at the point of care to detect, stage and track neuropathies. The company was incorporated in 1996 and based in Woburn, Massachusetts. Its shares were delisted from the Nasdaq in May 2025, last trading on May 1, 2025 at $4.58.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Woburn, MA
- Employees
- 13
- IPO date
- January 2, 2001
- Delisted
- May 1, 2025
- SEC CIK
- 1289850
NeuroMetrix financials before the delisting
The last 5 fiscal years NeuroMetrix reported as a public company, fiscal year ending December.
NURO revenue and net income
NURO earnings per share
NURO annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $3.03M | −$7.8M | — |
| FY2023 | $5.90M | −$6.5M | −$1.68 |
| FY2022 | $8.26M | −$4.4M | −$1.61 |
| FY2021 | $8.25M | −$2.2M | −$2.41 |
| FY2020 | $7.38M | −$2.0M | −$0.89 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
NeuroMetrix stock FAQ
What happened to NeuroMetrix stock?
NeuroMetrix was delisted from the Nasdaq in May 2025. The final close was $4.58 on May 1, 2025.
Can I still buy NURO stock?
No. NURO is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on May 1, 2025.
What was the last price of NURO?
NURO last closed at $4.58 on May 1, 2025, which valued the company at about $9.43M.
How did NeuroMetrix do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, NeuroMetrix reported revenue of $3.03M and net income of −$7.8M.
When did NeuroMetrix go public?
NeuroMetrix shares started trading on January 2, 2001.
NURO no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.